A Solari1, A Giordano2, M G Grasso3, P Confalonieri2, F Patti4, A Lugaresi5, L Palmisano6, R Amadeo7, G Martino7, M Ponzio8, G Casale9, C Borreani10, R Causarano11, S Veronese12, P Zaratin8, M A Battaglia8. 1. Unit of Neuroepidemiology, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy. solari@istituto-besta.it. 2. Unit of Neuroepidemiology, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy. 3. Multiple Sclerosis Unit, Foundation IRCCS S. Lucia Rehabilitation Hospital, Rome, Italy. 4. Department of Medical and Surgical Sciences and Advanced Technologies, University of Catania; MS Center, Neurology Clinic, University Hospital Policlinico Vittorio Emanuele, Catania, Italy. 5. Department of Neuroscience, Imaging and Clinical Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti, Italy. 6. Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Rome, Italy. 7. Associazione Italiana Sclerosi Multipla, Genoa, Italy. 8. Fondazione Italiana Sclerosi Multipla, Genoa, Italy. 9. Antea Charitable Association, Rome, Italy. 10. Unit of Clinical Psychology, Foundation IRCCS Istituto Nazionale per la Cura dei Tumori, Milan, Italy. 11. Unit of Palliative Care-Hospice, Niguarda Ca' Granda Hospital, Milan, Italy. 12. FARO Charitable Foundation, Turin, Italy.
Unfortunately, the original version of this article [1] contained an error. The affiliation section for Luigi Tesio in Appendix 1 of this article was included incorrectly as it was missing a second affiliation. The correct affiliations for Luigi Tesio can be found below.Department of Biomedical Sciences for Health, Università degli Studi,The Istituto Auxologico Italiano, IRCCS, Milan, Italy
Authors: Alessandra Solari; Andrea Giordano; Maria Grazia Grasso; Paolo Confalonieri; Francesco Patti; Alessandra Lugaresi; Lucia Palmisano; Roberta Amadeo; Giovanni Martino; Michela Ponzio; Giuseppe Casale; Claudia Borreani; Renzo Causarano; Simone Veronese; Paola Zaratin; Mario Alberto Battaglia Journal: Trials Date: 2015-04-23 Impact factor: 2.279